Cargando…
Higher proinflammatory responses possibly contributing to suppressed cytotoxicity in patients with COVID-19 associated mucormycosis
INTRODUCTION: COVID-19 Associated Mucormycosis (CAM), an opportunistic fungal infection, surged during the second wave of SARS Cov-2 pandemic. Since immune responses play an important role in controlling this infection in immunocompetent hosts, it is required to understand immune perturbations assoc...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier GmbH.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10089671/ https://www.ncbi.nlm.nih.gov/pubmed/37071959 http://dx.doi.org/10.1016/j.imbio.2023.152384 |
_version_ | 1785022810241892352 |
---|---|
author | Shete, Ashwini Deshpande, Supriya Sawant, Jyoti Warthe, Nidhi Thakar, Madhuri Madkaikar, Manisha Pradhan, Vandana Rao, Prajwal Rohatgi, Shalesh Mukherjee, Aparna Anand, Tanu Satija, Aanchal Sharma Velamuri, Poonam Das, Madhuchhanda Deasi, Nidhi Kumar Tembhurne, Alok Yadav, Reetika Pawaskar, Swapnal Rajguru, Chhaya Sankhe, Lalitkumar R. Chavan, Shrinivas S. Panda, Samiran |
author_facet | Shete, Ashwini Deshpande, Supriya Sawant, Jyoti Warthe, Nidhi Thakar, Madhuri Madkaikar, Manisha Pradhan, Vandana Rao, Prajwal Rohatgi, Shalesh Mukherjee, Aparna Anand, Tanu Satija, Aanchal Sharma Velamuri, Poonam Das, Madhuchhanda Deasi, Nidhi Kumar Tembhurne, Alok Yadav, Reetika Pawaskar, Swapnal Rajguru, Chhaya Sankhe, Lalitkumar R. Chavan, Shrinivas S. Panda, Samiran |
author_sort | Shete, Ashwini |
collection | PubMed |
description | INTRODUCTION: COVID-19 Associated Mucormycosis (CAM), an opportunistic fungal infection, surged during the second wave of SARS Cov-2 pandemic. Since immune responses play an important role in controlling this infection in immunocompetent hosts, it is required to understand immune perturbations associated with this condition for devising immunotherapeutic strategies for its control. We conducted a study to determine different immune parameters altered in CAM cases as compared to COVID-19 patients without CAM. METHODOLOGY: Cytokine levels in serum samples of CAM cases (n = 29) and COVID-19 patients without CAM (n = 20) were determined using luminex assay. Flow cytometric assays were carried out in 20 CAM cases and 10 controls for determination of frequency of NK cells, DCs, phagocytes, T cells and their functionalities. The cytokine levels were analyzed for their association with each other as well as with T cell functionality. The immune parameters were also analyzed with respect to the known risk factors such as diabetes mellitus and steroid treatment. RESULTS: Significant reduction in frequencies of total and CD56 + CD16 + NK cells (cytotoxic subset) was noted in CAM cases. Degranulation responses indicative of cytotoxicity of T cell were significantly hampered in CAM cases as compared to the controls. Conversely, phagocytic functions showed no difference in CAM cases versus their controls except for migratory potential which was found to be enhanced in CAM cases. Levels of proinflammatory cytokines such as IFN-γ, IL-2, TNF-α, IL-17, IL-1β, IL-18 and MCP-1 were significantly elevated in cases as compared to the control with IFN-γ and IL-18 levels correlating negatively with CD4 T cell cytotoxicity. Steroid administration was associated with higher frequency of CD56 + CD16- NK cells (cytokine producing subset) and higher MCP-1 levels. Whereas diabetic participants had higher phagocytic and chemotactic potential and had higher levels of IL-6, IL-17 and MCP-1. CONCLUSION: CAM cases differed from the controls in terms of higher titers of proinflammatory cytokines, reduced frequency of total and cytotoxic CD56 + CD16 + NK cell. They also had reduced T cell cytotoxicity correlating inversely with IFN-γ and IL-18 levels, possibly indicating induction of negative feedback mechanisms while diabetes mellitus or steroid administration did not affect the responses negatively. |
format | Online Article Text |
id | pubmed-10089671 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Elsevier GmbH. |
record_format | MEDLINE/PubMed |
spelling | pubmed-100896712023-04-12 Higher proinflammatory responses possibly contributing to suppressed cytotoxicity in patients with COVID-19 associated mucormycosis Shete, Ashwini Deshpande, Supriya Sawant, Jyoti Warthe, Nidhi Thakar, Madhuri Madkaikar, Manisha Pradhan, Vandana Rao, Prajwal Rohatgi, Shalesh Mukherjee, Aparna Anand, Tanu Satija, Aanchal Sharma Velamuri, Poonam Das, Madhuchhanda Deasi, Nidhi Kumar Tembhurne, Alok Yadav, Reetika Pawaskar, Swapnal Rajguru, Chhaya Sankhe, Lalitkumar R. Chavan, Shrinivas S. Panda, Samiran Immunobiology Article INTRODUCTION: COVID-19 Associated Mucormycosis (CAM), an opportunistic fungal infection, surged during the second wave of SARS Cov-2 pandemic. Since immune responses play an important role in controlling this infection in immunocompetent hosts, it is required to understand immune perturbations associated with this condition for devising immunotherapeutic strategies for its control. We conducted a study to determine different immune parameters altered in CAM cases as compared to COVID-19 patients without CAM. METHODOLOGY: Cytokine levels in serum samples of CAM cases (n = 29) and COVID-19 patients without CAM (n = 20) were determined using luminex assay. Flow cytometric assays were carried out in 20 CAM cases and 10 controls for determination of frequency of NK cells, DCs, phagocytes, T cells and their functionalities. The cytokine levels were analyzed for their association with each other as well as with T cell functionality. The immune parameters were also analyzed with respect to the known risk factors such as diabetes mellitus and steroid treatment. RESULTS: Significant reduction in frequencies of total and CD56 + CD16 + NK cells (cytotoxic subset) was noted in CAM cases. Degranulation responses indicative of cytotoxicity of T cell were significantly hampered in CAM cases as compared to the controls. Conversely, phagocytic functions showed no difference in CAM cases versus their controls except for migratory potential which was found to be enhanced in CAM cases. Levels of proinflammatory cytokines such as IFN-γ, IL-2, TNF-α, IL-17, IL-1β, IL-18 and MCP-1 were significantly elevated in cases as compared to the control with IFN-γ and IL-18 levels correlating negatively with CD4 T cell cytotoxicity. Steroid administration was associated with higher frequency of CD56 + CD16- NK cells (cytokine producing subset) and higher MCP-1 levels. Whereas diabetic participants had higher phagocytic and chemotactic potential and had higher levels of IL-6, IL-17 and MCP-1. CONCLUSION: CAM cases differed from the controls in terms of higher titers of proinflammatory cytokines, reduced frequency of total and cytotoxic CD56 + CD16 + NK cell. They also had reduced T cell cytotoxicity correlating inversely with IFN-γ and IL-18 levels, possibly indicating induction of negative feedback mechanisms while diabetes mellitus or steroid administration did not affect the responses negatively. Elsevier GmbH. 2023-05 2023-04-11 /pmc/articles/PMC10089671/ /pubmed/37071959 http://dx.doi.org/10.1016/j.imbio.2023.152384 Text en © 2023 Elsevier GmbH. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Shete, Ashwini Deshpande, Supriya Sawant, Jyoti Warthe, Nidhi Thakar, Madhuri Madkaikar, Manisha Pradhan, Vandana Rao, Prajwal Rohatgi, Shalesh Mukherjee, Aparna Anand, Tanu Satija, Aanchal Sharma Velamuri, Poonam Das, Madhuchhanda Deasi, Nidhi Kumar Tembhurne, Alok Yadav, Reetika Pawaskar, Swapnal Rajguru, Chhaya Sankhe, Lalitkumar R. Chavan, Shrinivas S. Panda, Samiran Higher proinflammatory responses possibly contributing to suppressed cytotoxicity in patients with COVID-19 associated mucormycosis |
title | Higher proinflammatory responses possibly contributing to suppressed cytotoxicity in patients with COVID-19 associated mucormycosis |
title_full | Higher proinflammatory responses possibly contributing to suppressed cytotoxicity in patients with COVID-19 associated mucormycosis |
title_fullStr | Higher proinflammatory responses possibly contributing to suppressed cytotoxicity in patients with COVID-19 associated mucormycosis |
title_full_unstemmed | Higher proinflammatory responses possibly contributing to suppressed cytotoxicity in patients with COVID-19 associated mucormycosis |
title_short | Higher proinflammatory responses possibly contributing to suppressed cytotoxicity in patients with COVID-19 associated mucormycosis |
title_sort | higher proinflammatory responses possibly contributing to suppressed cytotoxicity in patients with covid-19 associated mucormycosis |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10089671/ https://www.ncbi.nlm.nih.gov/pubmed/37071959 http://dx.doi.org/10.1016/j.imbio.2023.152384 |
work_keys_str_mv | AT sheteashwini higherproinflammatoryresponsespossiblycontributingtosuppressedcytotoxicityinpatientswithcovid19associatedmucormycosis AT deshpandesupriya higherproinflammatoryresponsespossiblycontributingtosuppressedcytotoxicityinpatientswithcovid19associatedmucormycosis AT sawantjyoti higherproinflammatoryresponsespossiblycontributingtosuppressedcytotoxicityinpatientswithcovid19associatedmucormycosis AT warthenidhi higherproinflammatoryresponsespossiblycontributingtosuppressedcytotoxicityinpatientswithcovid19associatedmucormycosis AT thakarmadhuri higherproinflammatoryresponsespossiblycontributingtosuppressedcytotoxicityinpatientswithcovid19associatedmucormycosis AT madkaikarmanisha higherproinflammatoryresponsespossiblycontributingtosuppressedcytotoxicityinpatientswithcovid19associatedmucormycosis AT pradhanvandana higherproinflammatoryresponsespossiblycontributingtosuppressedcytotoxicityinpatientswithcovid19associatedmucormycosis AT raoprajwal higherproinflammatoryresponsespossiblycontributingtosuppressedcytotoxicityinpatientswithcovid19associatedmucormycosis AT rohatgishalesh higherproinflammatoryresponsespossiblycontributingtosuppressedcytotoxicityinpatientswithcovid19associatedmucormycosis AT mukherjeeaparna higherproinflammatoryresponsespossiblycontributingtosuppressedcytotoxicityinpatientswithcovid19associatedmucormycosis AT anandtanu higherproinflammatoryresponsespossiblycontributingtosuppressedcytotoxicityinpatientswithcovid19associatedmucormycosis AT satijaaanchal higherproinflammatoryresponsespossiblycontributingtosuppressedcytotoxicityinpatientswithcovid19associatedmucormycosis AT sharmavelamuripoonam higherproinflammatoryresponsespossiblycontributingtosuppressedcytotoxicityinpatientswithcovid19associatedmucormycosis AT dasmadhuchhanda higherproinflammatoryresponsespossiblycontributingtosuppressedcytotoxicityinpatientswithcovid19associatedmucormycosis AT deasinidhi higherproinflammatoryresponsespossiblycontributingtosuppressedcytotoxicityinpatientswithcovid19associatedmucormycosis AT kumartembhurnealok higherproinflammatoryresponsespossiblycontributingtosuppressedcytotoxicityinpatientswithcovid19associatedmucormycosis AT yadavreetika higherproinflammatoryresponsespossiblycontributingtosuppressedcytotoxicityinpatientswithcovid19associatedmucormycosis AT pawaskarswapnal higherproinflammatoryresponsespossiblycontributingtosuppressedcytotoxicityinpatientswithcovid19associatedmucormycosis AT rajguruchhaya higherproinflammatoryresponsespossiblycontributingtosuppressedcytotoxicityinpatientswithcovid19associatedmucormycosis AT sankhelalitkumarr higherproinflammatoryresponsespossiblycontributingtosuppressedcytotoxicityinpatientswithcovid19associatedmucormycosis AT chavanshrinivass higherproinflammatoryresponsespossiblycontributingtosuppressedcytotoxicityinpatientswithcovid19associatedmucormycosis AT pandasamiran higherproinflammatoryresponsespossiblycontributingtosuppressedcytotoxicityinpatientswithcovid19associatedmucormycosis |